Shopping Cart
- Remove All
- Your shopping cart is currently empty
Plasma kallikrein-IN-3, a potent inhibitor ( IC 50 : 0.15 μM) of plasma kallikrein, finds application in research related to hereditary angioedema, diabetic macular edema, and diabetic retinopathy [1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $1,520 | 6-8 weeks | |
50 mg | $1,980 | 6-8 weeks | |
100 mg | $2,500 | 6-8 weeks |
Description | Plasma kallikrein-IN-3, a potent inhibitor ( IC 50 : 0.15 μM) of plasma kallikrein, finds application in research related to hereditary angioedema, diabetic macular edema, and diabetic retinopathy [1]. |
In vitro | Plasma kallikrein-IN-3 (example 13, ranging from 1 nM to 100 μM, for 1 hour) effectively inhibits plasma kallikrein activity with an IC50 value of 0.15 μM [1]. |
Molecular Weight | 365.43 |
Formula | C20H23N5O2 |
Cas No. | 1357950-47-0 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.